Lv01
0 积分 2024-09-01 加入
Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity
1小时前
待确认
Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity
1小时前
已完结
Neratinib, a Clinical Drug Against Breast Cancer, Protects Against Vascular Inflammation and Atherosclerosis
3个月前
已完结
Neratinib, a Clinical Drug Against Breast Cancer, Protects Against Vascular Inflammation and Atherosclerosis
3个月前
已完结